<DOC>
	<DOCNO>NCT00006459</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . It yet know paclitaxel effective without gemcitabine advance breast cancer . PURPOSE : Randomized phase III trial study effectiveness paclitaxel without gemcitabine treat woman advance breast cancer .</brief_summary>
	<brief_title>Paclitaxel With Without Gemcitabine Treating Women With Advanced Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare overall survival patient unresectable , locally recurrent , metastatic breast cancer treat paclitaxel without gemcitabine . OUTLINE : This randomize , multicenter study . Patients randomize one two treatment arm . Patients receive paclitaxel without gemcitabine . Treatment continue every 21 day absence disease progression . Patients follow every 2-4 month 2 year active treatment . PROJECTED ACCRUAL : Not specify National Cancer Institute ( NCI ) register trial Eli Lilly sponsor . NCI update record trial complete . In June 2012 , NCI transfer trial Lilly 's clinicaltrials.gov account Lilly update record trial completion date . This trial applicable trial Food Drug Administration Amendments Act 2007 ( FDAAA ) .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically proven unresectable , locally recurrent , metastatic breast cancer amenable surgery radiotherapy curative intent No inflammatory breast cancer unless evidence metastatic disease No bone metastasis , pleural effusion , ascites site disease Clinically measurable disease outside previously irradiate area Relapse 1 prior adjuvant neoadjuvant chemotherapy regimen contain anthracycline unless clinically contraindicate No know suspect brain metastasis recurrence require steroid radiotherapy Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : 18 Sex : Female Menopausal status : Not specify Performance status : Karnofsky 70100 % Life expectancy : At least 12 week Hematopoietic : Absolute granulocyte count least 1,500/mm3 Platelet count least 100,000/mm3 Hemoglobin least 9.0 g/dL Hepatic : ALT AST great 2 time upper limit normal ( ULN ) Bilirubin great 1.5 time ULN Renal : Calcium great 1.2 time ULN Creatinine great 1.5 time ULN Cardiovascular : No active uncontrolled cardiac disease and/or myocardial infarction within past 6 month Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 3 month completion study No prior malignancy within past 5 year except adequately treat basal cell squamous cell skin cancer carcinoma situ cervix No serious systemic disorder preclude study No active infection No severe psychiatric disease No history hypersensitivity reaction polyoxyethylated castor oilbased drug PRIOR CONCURRENT THERAPY : Biologic therapy : No prior bone marrow transplantation autologous stem cell infusion follow highdose adjuvant chemotherapy metastatic disease No concurrent immunotherapy ( include humanize antiHER2 antibody ) Chemotherapy : See Disease Characteristics See Biologic therapy No prior chemotherapy metastatic breast cancer No prior gemcitabine taxane No concurrent chemotherapy Endocrine therapy : See Disease Characteristics Prior antitumoral hormonal therapy allow No concurrent hormonal therapy exclude contraceptive replacement steroid Radiotherapy : See Disease Characteristics At least 2 week since prior radiotherapy recover No concurrent radiotherapy Surgery : See Disease Characteristics Other : Recovered prior therapy At least 30 day since prior investigational drug No concurrent investigational drug Concurrent bisphosphonate therapy allow begin stop within 4 week study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2002</verification_date>
	<keyword>stage IV breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>recurrent breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
</DOC>